Navigation Links
FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGIC'S PANTHER SYSTEM
Date:7/23/2013

BEDFORD, Mass., July 23, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration (FDA) has approved Hologic's Aptima HPV assay for use on the Company's fully-automated Panther system. The Aptima HPV test is performed with Hologic's ThinPrep liquid cytology specimen and can be tested before and after it has been processed for cytology testing on the ThinPrep 2000 system.

Hologic's Aptima HPV mRNA based assay is a nucleic acid amplified test that detects 14 high-risk strains of human papillomavirus (HPV) associated with cervical cancer and precancerous lesions, and has demonstrated significantly improved specificity with no compromise in disease detection. The addition of the Aptima HPV assay to the Panther menu extends the capability of low to high-volume laboratories to run multiple tests from a single specimen, on a cost effective, highly flexible and fully-automated molecular testing platform.

Created to be a "sample-in-result-out" instrument, the Panther system eliminates batch processing and automates all aspects of nucleic acid testing on a single, integrated platform.

"Our Panther system is a world-class automation solution for a broad range of molecular diagnostic laboratories," said Rohan Hastie, Senior Vice President and General Manager, Diagnostics. "Expanding the menu of available assays on Panther builds on our platform-centric strategy of delivering workflow efficiencies and revenue generating opportunities to our laboratory partners."

About the Hologic Aptima HPV Assay

The Aptima HPV assay detects messenger RNA overexp
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
2. FDA Approves NDA Supported By MedAvante Central Ratings
3. Cardinal Health Board Of Directors Approves Cash Dividend; Authorizes New $750 Million Share Repurchase Program
4. FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
5. Specialty Pharmacy Certification Board (SPCB) Approves Content for Certified Specialty Pharmacist (CSP) Certification Exam
6. Aushon to Launch New Multiplex Immunoassay Platform
7. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
8. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
9. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
10. AIT Bioscience Taps Ligand Binding Assay Expert Dr. Ron Bowsher as Senior Research Advisor
11. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... -- Former NASA scientist Tamim Hamid was ... discussed Theradome™, the first portable and wearable OTC hair ... firsthand how, via laser technology, Theradome™ offers individuals a ... not require surgery or medication.  "The ... the hair follicle, which is where the stem cells ...
(Date:5/4/2015)... May 4, 2015 PAREXEL International Corporation (NASDAQ: ... the UBS Healthcare Conference on Monday, May 18, 2015, in ... and Chief Financial Officer will be making a presentation on ... A live webcast of the presentation will be available ... in the Upcoming Events portion of the main page, ...
(Date:5/4/2015)... , May 4, 2015 Rogne Bioscience, ... psoriasis, today announced that preclinical and mechanism of action ... the Society of Investigative Dermatology (SID) Annual Meeting being ... Atlanta, Georgia . Logo - ... the development of RON2315, a novel, low MW (<1700 ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2PAREXEL International to Present at UBS Healthcare Conference 2Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2
... , POINT RICHMOND, Calif., Nov. 12 Transcept Pharmaceuticals, ... focused on the development and commercialization of proprietary products ... financial results for the three and nine months ended ... that on October 28, 2009, the FDA issued a ...
... / -- New research findings presented today ... International Conference in New York show promise in ... alternative medicine (CAM) using traditional research methods. Susan ... and Clinics of Minnesota (Children,s), presented findings on ...
Cached Medicine Technology:Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 2Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 3Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 4Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 5Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 6Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 7Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 9Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 10Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 11Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results 12New Research Shows Promise in Using Traditional Research Methods to Assess Efficacy of Complementary Therapies 2
(Date:5/4/2015)... 05, 2015 The National Association ... Betancourt as a 2015-2016 inductee into the NAPW ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor," said NAPW President Star Jones. ...
(Date:5/4/2015)... Every Friday afternoon at A Forever ... Southwest Michigan, patients and staff gather in the common ... rehabilitation program and to gain encouragement and inspiration in ... One by one, those patients who have completed their ... certificates and to share a bit about their journey ...
(Date:5/4/2015)... Montreal, CANADA (PRWEB) May 04, 2015 ... development of innovative proofreading technologies, today announced that ... #438 at the Music City Center, in Nashville ... Proofware is the world's first true all-in-one we-based ... everyone involved in the security of their brand ...
(Date:5/4/2015)... City, MO (PRWEB) May 04, 2015 ... vice president and chief physician executive, and William C. ... have received and accepted personal invitations from the Secretary ... National Security Forum (NSF) at the Air War College, ... is to expose influential citizens to senior U.S. and ...
(Date:5/4/2015)... Milton Hershey School® has named J. ... the Year, recognizing his commitment to pediatric cancer research ... for MHS students. , “Dr. Graves is a tremendous ... are provided a top-notch education, a nurturing environment, and ... Pete Gurt ’85, president of MHS. “He is applying ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2
... Enjoy Broad Choice of,Prescription Drugs, WASHINGTON, Jan. 31 ... statement on new budget,figures that report the cost of ... years than was estimated last summer:, "Part D ... drugs. New budget documents show that the overall,projected cost ...
... 2008. As part of its ongoing efforts to do ... and a cure for Parkinson,s disease, The Michael J. ... $3 million in total funding to four industry teams ... the clinic. The awards were granted under MJFF,s Therapeutics ...
... Schering-Plough,Corporation (NYSE: SGP ) today reported ... received an A-1 recommendation(1) (highest,rating) for the ... risk patients in the latest Treatment of ... Society of America (IDSA),released this month. The ...
... Jan. 31 Cardinal Health, a,global provider of products ... care, today announced the resignation of Matthew D.,Walter from ... quarterly dividend., "We want to thank Matt for ... John B. McCoy, chairman of the Nominating and,Governance Committee. ...
... Jan. 31 National opinion leaders will,convene in ... latest data,guidelines, practical applications, and strategies for the ... to make the,meeting highly interactive., The Summit ... credits sponsored,by The Dannemiller Educational Foundation, and the ...
... a gene that is the key switch that allows ... Much like students in a kindergarten class lining up ... identified as Smarcd3, must align correctly with two other ... as myogenesis, said principal investigator Monte Westerfield, a professor ...
Cached Medicine News:Health News:Michael J. Fox Foundation awards up to $3 million to industry teams 2Health News:Michael J. Fox Foundation awards up to $3 million to industry teams 3Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 2Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 3Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 4Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 5Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 6Health News:Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3Health News:Oregon researchers find trigger gene for muscle development 2
... medication nebulizer achieves optimum lung penetration for ... range is 1.04-1.10 µ at 6-8 LPM. ... outlet., ,As the world leader in ... the assurance of proven technology by offering ...
... breakthrough continuous low-flow nebulizer performance. Patented ... technology allows for optimal medication and ... Heliox). OMNI~NEB takes on severe asthma, ... and critical care situations. Configure with ...
... offer a spill-proof design and effective output, ... angle. All medical nebulizers are free-standing for ... configurations are available., ,All Portex® medication ... medication nebulizers feature consistently fine misting and ...
... a spill-proof design and effective output, even ... All medical nebulizers are free-standing for easy ... are available., ,All Portex® medication nebulizer ... nebulizers feature consistently fine misting and the ...
Medicine Products: